Why Patient Diversity Is Key to Better Clinical Trial Outcomes
Beyond being a regulatory checkbox, patient diversity is a critical factor in developing safer, more effective medical treatments for everyone. When diversity is missing, the consequences are concrete and sometimes severe: Safety signals get missed. Adverse events that show up only in specific populations may go undetected until after a drug reaches the market. Efficacy […]